reiterateSfinnhub
TD Cowen Reiterates Buy Rating on SentinelOne, Inc. (S)
TD Cowen reiterated its Buy rating on SentinelOne, Inc. (NYSE:S) on August 17, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
TD Cowen reiterated its Buy rating on SentinelOne, Inc. (NYSE:S) on August 17, 2026.
Read moreDA Davidson reiterated its Neutral rating on Brunswick Corporation (NYSE:BC) on August 17, 2026.
Read moreBarclays reiterated its Equal-Weight rating on APA Corporation (NASDAQ:APA) on August 17, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Camden Property Trust (NYSE:CPT) on August 17, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Antero Resources Corporation (NYSE:AR) on August 17, 2026.
Read moreUBS reiterated its Sell rating on Dillard's, Inc. (NYSE:DDS) on August 17, 2026.
Read moreJP Morgan reiterated its Underweight rating on Dillard's, Inc. (NYSE:DDS) on August 17, 2026.
Read moreEvercore ISI Group reiterated its In-Line rating on Consolidated Edison, Inc. (NYSE:ED) on August 17, 2026.
Read moreBarclays reiterated its Overweight rating on EQT Corporation (NYSE:EQT) on August 17, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Soluna Holdings, Inc.
Read moreCantor Fitzgerald reiterated its Overweight rating on CVRx, Inc. (NASDAQ:CVRX) on August 17, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on OmniAb, Inc.
Read moreCanaccord Genuity reiterated its Hold rating on Quanterix Corporation (NASDAQ:QTRX) on August 17, 2026.
Read moreCitizens reiterated its Market Underperform rating on Domo, Inc. (NASDAQ:DOMO) on August 17, 2026.
Read moreKeefe, Bruyette & Woods analysts downgraded Crescent Capital BDC, Inc. (NASDAQ:CCAP) from Outperform to Market Perform on August 17, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Alto Neuroscience, Inc.
Read moreCitizens reiterated its Market Outperform rating on Allogene Therapeutics, Inc. (NASDAQ:ALLO) on August 17, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on ArriVent BioPharma, Inc.
Read moreBarclays reiterated its Overweight rating on Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) on August 17, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on MiMedx Group, Inc. (NASDAQ:MDXG) on August 17, 2026.
Read more